SEC Form 10-Q filed by Vuzix Corporation
$VUZI
Radio And Television Broadcasting And Communications Equipment
Technology
Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/10/2023 | Buy → Neutral | BTIG Research | |
| 12/21/2021 | $15.00 | Buy | Dawson James |
4 - Vuzix Corp (0001463972) (Issuer)
4 - Vuzix Corp (0001463972) (Issuer)
3 - Vuzix Corp (0001463972) (Issuer)
- Unlocked third Quanta Computer investment tranche, receiving $5 million and bringing total investment to $20 million - Appointed Dr. Chris Parkinson, as President, Vuzix Enterprise Solutions - Received first wave of volume purchase orders from a leading global online retailer - Awarded six‑figure development order from a leading U.S. defense contractor - Ended the quarter with $22.6 million in cash; Q3 operating expenses down 22% year-over-year ROCHESTER, N.Y., Nov. 13, 2025 /PRNewswire/ -- Vuzix® Corporation (NASDAQ:VUZI) ("Vuzix" or the "Company"), a leading supplier of AI-powered smart glasses, waveguides and Augmented Reality (AR) technologies, today reported its f
ROCHESTER, N.Y., Nov. 12, 2025 /PRNewswire/ -- Vuzix® Corporation (NASDAQ:VUZI), ("Vuzix" or, the "Company"), a leading supplier of AI-powered smart glasses, waveguides, and Augmented Reality (AR) technologies, is pleased to announced that the Company will be participating in the 16th Annual Craig-Hallum Alpha Select Conference being held on November 18th, 2025 at the Sheraton New York Times Square Hotel in New York City. Institutional investors attending the conference are welcome to request a 1-on-1 meeting with company management via their Craig-Hallum salesperson. About Vu
ROCHESTER, N.Y., Oct. 30, 2025 /PRNewswire/ -- Vuzix® Corporation (NASDAQ:VUZI), ("Vuzix" or, the "Company"), a leading supplier of smart glasses, waveguides, and augmented reality (AR) technologies, is pleased to announce that the Company will host a conference call regarding its third quarter 2025 operating results at 4:30 PM Eastern Time (ET), November 13, 2025. To join the live conference call, please dial 877-709-8150 (U.S. and Canadian callers) or 201-689-8354 (international callers outside of the U.S. and Canada) 10 to 15 minutes prior to the scheduled call time. Partic
BTIG Research downgraded Vuzix from Buy to Neutral
Dawson James initiated coverage of Vuzix with a rating of Buy and set a new price target of $15.00
Maxim Group downgraded Vuzix from Buy to Hold
4 - Vuzix Corp (0001463972) (Issuer)
4 - Vuzix Corp (0001463972) (Issuer)
4 - Vuzix Corp (0001463972) (Issuer)
10-Q - Vuzix Corp (0001463972) (Filer)
S-3 - Vuzix Corp (0001463972) (Filer)
8-K - Vuzix Corp (0001463972) (Filer)
ROCHESTER, N.Y., Sept. 8, 2025 /PRNewswire/ -- Vuzix® Corporation (NASDAQ:VUZI), ("Vuzix" or, the "Company"), a leading supplier of AI-powered smart glasses, advanced waveguides, and augmented reality (AR) technologies for defense and enterprise applications, today announced the appointment of Dr. Chris Parkinson as President, Enterprise Solutions at Vuzix. A pioneer in enterprise smart glasses and the visionary co-founder behind RealWear, Dr. Parkinson joins Vuzix to lead its enterprise business into a new era of strategic growth, platform resilience, and global scale. Dr. Pa
ROCHESTER, N.Y., May 27, 2025 /PRNewswire/ -- Vuzix® Corporation (NASDAQ:VUZI), ("Vuzix" or, the "Company"), a leading supplier of smart glasses, waveguides, and augmented reality (AR) technologies, today announced that it is set to join the broad-market Russell 3000® Index at the conclusion of the 2025 Russell indexes annual reconstitution, according to a preliminary list of additions posted by FTSE Russell on May 23, 2025. Vuzix' inclusion will become effective after the US market opens on June 27. Annual Russell indexes reconstitution captures the 3,000 largest US stocks, r
Ophthalmologist Doctor Shabbir Khambati appointed as a founding board memberROCHESTER, N.Y., Jan. 29, 2024 /PRNewswire/ -- Vuzix® Corporation (NASDAQ:VUZI), ("Vuzix" or, the "Company"), a leading supplier of smart glasses and Augmented Reality (AR) technology and products, today announced that it has established an Optometry Advisory Board (OAB), whose primary purpose will be to provide strategic input, guidance, and recommendations to Company management on vision correction issues and how to better build products and services to meet Vuzix' customer vision requirements. The Company also announces the appointment of Doctor Shabbir Khambati to this board as the chair and a founding board mem
- Unlocked third Quanta Computer investment tranche, receiving $5 million and bringing total investment to $20 million - Appointed Dr. Chris Parkinson, as President, Vuzix Enterprise Solutions - Received first wave of volume purchase orders from a leading global online retailer - Awarded six‑figure development order from a leading U.S. defense contractor - Ended the quarter with $22.6 million in cash; Q3 operating expenses down 22% year-over-year ROCHESTER, N.Y., Nov. 13, 2025 /PRNewswire/ -- Vuzix® Corporation (NASDAQ:VUZI) ("Vuzix" or the "Company"), a leading supplier of AI-powered smart glasses, waveguides and Augmented Reality (AR) technologies, today reported its f
ROCHESTER, N.Y., Oct. 30, 2025 /PRNewswire/ -- Vuzix® Corporation (NASDAQ:VUZI), ("Vuzix" or, the "Company"), a leading supplier of smart glasses, waveguides, and augmented reality (AR) technologies, is pleased to announce that the Company will host a conference call regarding its third quarter 2025 operating results at 4:30 PM Eastern Time (ET), November 13, 2025. To join the live conference call, please dial 877-709-8150 (U.S. and Canadian callers) or 201-689-8354 (international callers outside of the U.S. and Canada) 10 to 15 minutes prior to the scheduled call time. Partic
ROCHESTER, N.Y., Aug. 14, 2025 /PRNewswire/ -- Vuzix® Corporation (NASDAQ:VUZI) ("Vuzix" or the "Company"), a leading supplier of AI-powered smart glasses, waveguides and Augmented Reality (AR) technologies, today reported its second quarter results for the three months ended June 30, 2025. "During the second quarter of 2025, Vuzix met all the manufacturing and performance gates tied to receipt of the second Quanta tranche and received that $5 million, bringing Quanta's investment thus far to $15 million out of a planned $20 million," said Paul Travers, President and CEO of Vu
SC 13G/A - Vuzix Corp (0001463972) (Subject)
SC 13G/A - Vuzix Corp (0001463972) (Subject)
SC 13G - Vuzix Corp (0001463972) (Subject)